Back to Search
Start Over
Xanthobacter sp. C20 contains a novel bioconversion pathway for limonene.
- Source :
-
Journal of biotechnology [J Biotechnol] 2001 Nov 30; Vol. 84 (2), pp. 133-43. - Publication Year :
- 2001
-
Abstract
- Xanthobacter sp. C20 was isolated from sediment of the river Rhine using cyclohexane as sole source of carbon and energy. Xanthobacter sp. C20 converted both enantiomers of limonene quantitatively into limonene-8,9-epoxide, a not previously described bioconversion product of limonene. With (4R)-limonene, (4R,8R)-limonene-8, 9-epoxide was formed as the only reaction product, while (4S)-limonene was converted into a (78:22) mixture of (4S,8R)- and (4S,8S)-limonene-8,9-epoxide. Cytochrome P-450 was shown to be induced concomitantly with limonene bioconversion activity following growth of Xanthobacter sp. C20 on cyclohexane. Maximal limonene bioconversion rate was observed at an initial substrate concentration of 12 mM. The amount of limonene-8,9-epoxide formed, up to 0.8 g l(-1), was limited by a strong product inhibition.
- Subjects :
- Cyclohexane Monoterpenes
Cyclohexanes metabolism
Cyclohexanes pharmacology
Cyclohexenes
Zingiber officinale chemistry
Zingiber officinale metabolism
Limonene
Menthol chemistry
Menthol metabolism
Monoterpenes
Oxidation-Reduction
Plants, Medicinal
Stereoisomerism
Terpenes chemistry
Xanthobacter classification
Cytochrome P-450 Enzyme System metabolism
Food Microbiology
Industrial Microbiology methods
Terpenes metabolism
Xanthobacter enzymology
Subjects
Details
- Language :
- English
- ISSN :
- 0168-1656
- Volume :
- 84
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 11090685
- Full Text :
- https://doi.org/10.1016/s0168-1656(00)00348-5